Editorial Article
Optimize monoclonal antibody development with icIEF-UV/MS
Scientists at Johnson & Johnson Innovative Medicine are using the Intabio ZT system for the confident characterization of monoclonal antibodies
Products, services, reviews and techniques used in the identification and validation of the disease-causing target genes and proteins.
Scientists at Johnson & Johnson Innovative Medicine are using the Intabio ZT system for the confident characterization of monoclonal antibodies
